Fukoku Mutual Life Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$707K Sell
1,589
-226
-12% -$101K 0.05% 93
2025
Q1
$880K Sell
1,815
-40
-2% -$19.4K 0.07% 71
2024
Q4
$747K Hold
1,855
0.05% 84
2024
Q3
$863K Hold
1,855
0.06% 77
2024
Q2
$869K Sell
1,855
-166
-8% -$77.8K 0.07% 73
2024
Q1
$845K Sell
2,021
-119
-6% -$49.7K 0.07% 71
2023
Q4
$871K Sell
2,140
-500
-19% -$203K 0.07% 79
2023
Q3
$918K Buy
2,640
+500
+23% +$174K 0.08% 66
2023
Q2
$753K Hold
2,140
0.07% 75
2023
Q1
$674K Sell
2,140
-1,000
-32% -$315K 0.06% 81
2022
Q4
$907K Buy
3,140
+1,720
+121% +$497K 0.08% 73
2022
Q3
$411K Hold
1,420
0.04% 138
2022
Q2
$400K Sell
1,420
-30
-2% -$8.45K 0.03% 147
2022
Q1
$378K Sell
1,450
-100
-6% -$26.1K 0.03% 184
2021
Q4
$340K Buy
1,550
+60
+4% +$13.2K 0.03% 217
2021
Q3
$270K Sell
1,490
-210
-12% -$38.1K 0.02% 251
2021
Q2
$343K Hold
1,700
0.03% 185
2021
Q1
$365K Hold
1,700
0.04% 146
2020
Q4
$402K Hold
1,700
0.04% 136
2020
Q3
$463K Buy
1,700
+200
+13% +$54.5K 0.05% 120
2020
Q2
$435K Hold
1,500
0.05% 118
2020
Q1
$357K Hold
1,500
0.05% 112
2019
Q4
$328K Buy
1,500
+200
+15% +$43.7K 0.04% 177
2019
Q3
$220K Hold
1,300
0.03% 195
2019
Q2
$238K Hold
1,300
0.03% 176
2019
Q1
$239K Sell
1,300
-100
-7% -$18.4K 0.03% 165
2018
Q4
$232K Buy
1,400
+200
+17% +$33.1K 0.03% 170
2018
Q3
$231K Sell
1,200
-200
-14% -$38.5K 0.03% 193
2018
Q2
$238K Hold
1,400
0.03% 174
2018
Q1
$228K Hold
1,400
0.04% 173
2017
Q4
$210K Hold
1,400
0.03% 197
2017
Q3
$213K Sell
1,400
-100
-7% -$15.2K 0.03% 190
2017
Q2
$193K Hold
1,500
0.03% 210
2017
Q1
$164K Buy
1,500
+100
+7% +$10.9K 0.03% 209
2016
Q4
$103K Buy
1,400
+100
+8% +$7.36K 0.02% 252
2016
Q3
$113K Hold
1,300
0.02% 241
2016
Q2
$112K Hold
1,300
0.02% 246
2016
Q1
$103K Buy
1,300
+200
+18% +$15.8K 0.02% 252
2015
Q4
$138K Hold
1,100
0.02% 248
2015
Q3
$115K Buy
1,100
+500
+83% +$52.3K 0.02% 258
2015
Q2
$74K Hold
600
0.01% 300
2015
Q1
$71K Buy
600
+200
+50% +$23.7K 0.01% 298
2014
Q4
$48K Buy
+400
New +$48K 0.01% 309